Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy
Clinical trial NCT04159415 · COMPLETED
Trial details
- NCT number
- NCT04159415
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2022-01-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.